These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19937064)

  • 1. Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome.
    Yoon SH; Chung SK; Kim KJ; Kim HJ; Jin YJ; Kim HB
    Eur Spine J; 2010 Apr; 19(4):575-82. PubMed ID: 19937064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial therapy and assessing therapeutic response in culture-negative pyogenic vertebral osteomyelitis: a retrospective comparative study with culture-positive pyogenic vertebral osteomyelitis.
    Yu D; Kim SW; Jeon I
    BMC Infect Dis; 2020 Dec; 20(1):939. PubMed ID: 33297994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-4-week erythrocyte sedimentation rate variability predicts erythrocyte sedimentation rate trajectories and clinical course among patients with pyogenic vertebral osteomyelitis.
    Chiang HY; Chung CW; Kuo CC; Lo YC; Chang WS; Chi CY
    PLoS One; 2019; 14(12):e0225969. PubMed ID: 31800625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Guideline for Patients with Native Culture-negative Pyogenic Vertebral Osteomyelitis.
    Lee SH; Kim J; Kim TH
    Clin Orthop Relat Res; 2022 Jan; 480(1):124-136. PubMed ID: 34128841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pyogenic postoperative and native vertebral osteomyelitis.
    Kim UJ; Bae JY; Kim SE; Kim CJ; Kang SJ; Jang HC; Jung SI; Song KH; Kim ES; Kim HB; Park WB; Kim NJ; Park KH
    Spine J; 2019 May; 19(5):880-887. PubMed ID: 30500465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control study.
    Lemaignen A; Ghout I; Dinh A; Gras G; Fantin B; Zarrouk V; Carlier R; Loret JE; Denes E; Greder A; Lescure FX; Boutoille D; Tattevin P; Issartel B; Cottier JP; Bernard L;
    Medicine (Baltimore); 2017 May; 96(21):e6387. PubMed ID: 28538361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of culture-negative pyogenic vertebral osteomyelitis: comparison with microbiologically confirmed pyogenic vertebral osteomyelitis.
    Kim J; Kim YS; Peck KR; Kim ES; Cho SY; Ha YE; Kang CI; Chung DR; Song JH
    Semin Arthritis Rheum; 2014 Oct; 44(2):246-52. PubMed ID: 24951277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical use of erythrocyte sedimentation rate in pyogenic vertebral osteomyelitis.
    Carragee EJ; Kim D; van der Vlugt T; Vittum D
    Spine (Phila Pa 1976); 1997 Sep; 22(18):2089-93. PubMed ID: 9322319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for positive disco-vertebral biopsy culture in pyogenic vertebral osteomyelitis, and impact of fluoroscopic versus scanographic guidance.
    Diffre C; Jousset C; Roux AL; Duran C; Noussair L; Rottman M; Carlier RY; Dinh A
    BMC Infect Dis; 2020 Jul; 20(1):512. PubMed ID: 32677896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical and radiological magnetic resonance imaging outcome of abscess-associated spontaneous pyogenic vertebral osteomyelitis under conservative management.
    Euba G; Narváez JA; Nolla JM; Murillo O; Narváez J; Gómez-Vaquero C; Ariza J
    Semin Arthritis Rheum; 2008 Aug; 38(1):28-40. PubMed ID: 18055000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases.
    Colmenero JD; Jiménez-Mejías ME; Sánchez-Lora FJ; Reguera JM; Palomino-Nicás J; Martos F; García de las Heras J; Pachón J
    Ann Rheum Dis; 1997 Dec; 56(12):709-15. PubMed ID: 9496149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial.
    Bernard L; Dinh A; Ghout I; Simo D; Zeller V; Issartel B; Le Moing V; Belmatoug N; Lesprit P; Bru JP; Therby A; Bouhour D; Dénes E; Debard A; Chirouze C; Fèvre K; Dupon M; Aegerter P; Mulleman D;
    Lancet; 2015 Mar; 385(9971):875-82. PubMed ID: 25468170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes.
    Priest DH; Peacock JE
    South Med J; 2005 Sep; 98(9):854-62. PubMed ID: 16217976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of routine diagnostic tests for vertebral osteomyelitis may be influenced by the infecting organism.
    Ghassibi M; Yen TC; Harris S; Si Z; Leary E; Choma TJ
    Spine J; 2021 Sep; 21(9):1479-1488. PubMed ID: 33857669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis?
    Babouee Flury B; Elzi L; Kolbe M; Frei R; Weisser M; Schären S; Widmer AF; Battegay M
    BMC Infect Dis; 2014 Apr; 14():226. PubMed ID: 24767169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.
    Aspinall SL; Friedland DM; Yu VL; Rihs JD; Muder RR
    Ann Pharmacother; 1995; 29(7-8):694-7. PubMed ID: 8520082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral osteomyelitis at a Norwegian university hospital 1987-97: clinical features, laboratory findings and outcome.
    Chelsom J; Solberg CO
    Scand J Infect Dis; 1998; 30(2):147-51. PubMed ID: 9730301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposure.
    Kim CJ; Song KH; Park WB; Kim ES; Park SW; Kim HB; Oh MD; Kim NJ
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2122-4. PubMed ID: 22232286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Recurrence in Pyogenic Vertebral Osteomyelitis by Artificial Neural Network Using Time-series Data of C-Reactive Protein: A Retrospective Cohort Study of 704 Patients.
    Kim J; Ryu H; Kim SW; Oh JK; Kim TH
    Spine (Phila Pa 1976); 2021 Sep; 46(18):1207-1217. PubMed ID: 34435983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage management for vertebral osteomyelitis and epidural abscess: technical note.
    Nakase H; Matsuda R; Tamaki R; Tei R; Park YS; Sakaki T
    Neurosurgery; 2006 Jun; 58(6):E1219; discussion E1219. PubMed ID: 16723876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.